Product Name: AK4 (IgG1)
Background: CD62P (P-selectin) is an adhesion glycoprotein that is expressed on platelets and endothelial cells upon their activation. Interaction between CD62P and its mucin-like ligand PSGL-1 (P-selectin glycoprotein ligand-1) expressed on the microvilli of most le
Specificity: The antibody AK4 recognizes CD62P (P-selectin), a 140 kD single chain type I transmembrane glycoprotein present in secretory alpha-granules in platelets, in Weibel-Palade bodies in endothelial cells and in megakaryocytes; it is relocated to the plasma mem
Immunogen: Human platelets
CAS NO: 598-02-7
Product: Diethyl phosphate
Species Reactivity: HumanNon-Human Primates
Negative Species: Applications: Flow CytometryRecommended dilution:1.5 μg/mlImmunoprecipitationWestern BlottingImmunocytochemistryFunctional ApplicationBlocking
Applications: Flow CytometryRecommended dilution:1.5 μg/mlImmunoprecipitationWestern BlottingImmunocytochemistryFunctional ApplicationBlocking
PubMed ID:http://aac.asm.org/content/49/8/3109.abstract
Product Name: AK4 (IgG1)
Background: CD62P (P-selectin) is an adhesion glycoprotein that is expressed on platelets and endothelial cells upon their activation. Interaction between CD62P and its mucin-like ligand PSGL-1 (P-selectin glycoprotein ligand-1) expressed on the microvilli of most le
Specificity: The antibody AK4 recognizes CD62P (P-selectin), a 140 kD single chain type I transmembrane glycoprotein present in secretory alpha-granules in platelets, in Weibel-Palade bodies in endothelial cells and in megakaryocytes; it is relocated to the plasma mem
Immunogen: Human platelets
CAS NO: 1357470-29-1
Product: ON123300
Species Reactivity: HumanNon-Human Primates
Negative Species: Applications: Flow CytometryRecommended dilution:1.5 μg/mlImmunoprecipitationWestern BlottingImmunocytochemistryFunctional ApplicationBlocking
Applications: Flow CytometryRecommended dilution:1.5 μg/mlImmunoprecipitationWestern BlottingImmunocytochemistryFunctional ApplicationBlocking
PubMed ID:http://aac.asm.org/content/50/8/2869.abstract